Protherics PLC: Protherics PLC announces Rule 2.10 Announcement
Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 24/10/2008
... +44 (0) 20 7776 1203 Phil Walker, Director Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno +1 212 850 5600 Or visit Dealing Disclosure Requirements Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities"...
- add comment
- send to a friend
- Explore : Protherics Plc















